Evaluation and Management of Primary Hyperparathyroidism: Summary Statement and Guidelines from the Fifth International Workshop.
Bilezikian JP, Khan AA, Silverberg SJ, Fuleihan GE, Marcocci C, Minisola S, Perrier N, Sitges-Serra A, Thakker RV, Guyatt G, Mannstadt M, Potts JT, Clarke BL, Brandi ML; International Workshop on Primary Hyperparathyroidism.
J Bone Miner Res. 2022 Nov;37(11):2293-2314. doi: 10.1002/jbmr.4677. Epub 2022 Oct 17.
Primary hyperparathyroidism.
Kowalski GJ, Buła G, Żądło D, Gawrychowska A, Gawrychowski J.
Endokrynol Pol. 2020;71(3):260-270. doi: 10.5603/EP.a2020.0028.
Normocalcemic primary hyperparathyroidism.
Cusano NE, Cetani F.
Arch Endocrinol Metab. 2022 Nov 11;66(5):666-677. doi: 10.20945/2359-3997000000556.
Primary Hyperparathyroidism.
Masi L.
Front Horm Res. 2019;51:1-12. doi: 10.1159/000491034. Epub 2018 Nov 19.
Medical management of primary hyperparathyroidism.
Bandeira F, de Moura Nóbrega J, de Oliveira LB, Bilezikian J.
Arch Endocrinol Metab. 2022 Nov 11;66(5):689-693. doi: 10.20945/2359-3997000000558.
Hereditary Primary Hyperparathyroidism.
Newey PJ.
Endocrinol Metab Clin North Am. 2021 Dec;50(4):663-681. doi: 10.1016/j.ecl.2021.08.003.
Sporadic Primary Hyperparathyroidism.
Kim SJ, Shoback DM.
Endocrinol Metab Clin North Am. 2021 Dec;50(4):609-628. doi: 10.1016/j.ecl.2021.07.006.
Primary hyperparathyroidism.
Muñoz-Torres M, García-Martín A.
Med Clin (Barc). 2018 Mar 23;150(6):226-232. doi: 10.1016/j.medcli.2017.07.020. Epub 2017 Oct 6.
Asymptomatic Primary Hyperparathyroidism.
Clarke BL.
Front Horm Res. 2019;51:13-22. doi: 10.1159/000491035. Epub 2018 Nov 19.
Congenital primary hyperparathyroidism.
Marini F, Giusti F, Brandi ML.
Best Pract Res Clin Endocrinol Metab. 2025 Mar;39(2):101982. doi: 10.1016/j.beem.2025.101982. Epub 2025 Jan 31.
